figshare
Browse
MAS.zip (226.92 MB)

SGLT2 inhibition and prevention of diabetic nephropathy

Download (0 kB)
figure
posted on 2014-08-20, 13:38 authored by Muralikrishna Gangadharan komalaMuralikrishna Gangadharan komala

To look at in vivo eefct of empagliflozin in preventing diabetic nephropathy in the presence of high blood glucose. This study is aimed at looking at renoprotection of SGLT2 inhibition independent of its hypoglycaemic effect.

History

Usage metrics

    Categories

    Keywords

    EmpagliflozinMedicinePharmacology

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC